Siemens and Dräger are expanding their partnership

Drägerwerk AGDräger acquires 10 percent of Siemens AG shares in its Joint Venture Dräger Medical AG & Co. KG for a sales price of approximately 110 million EUR and increases its stake to 75 percent. At the same time, Siemens AG waves the sales option of its shares originally agreed in the Joint Venture contract and retains its 25 percent holding in the Dräger Medical Group. In addition, Siemens AG plans to purchase 2.5 percent of the Drägerwerk AG, probably in the form of common stock to be issued in the future.

"With an investment in Drägerwerk AG, we document that we want to intensify and continue our partnership," emphasizes Erich R. Reinhardt, member of the Executive Board of Siemens AG and CEO and President of Siemens Medical Solutions. "We have reached an excellent competitive position and are growing faster than the market," added Stefan Dräger, Chairman of Drägerwerk AG. Both companies have contributed to the development of Dräger Medical into one of the leading international manufacturers of medical therapy systems.

In 2003, Drägerwerk AG and Siemens AG founded the Joint Venture Dräger Medical AG & Co. KG, Lübeck. For fiscal year 2006, the total number of employees was at approximately 6,000, and sales of approx. 1.2 billion EUR and an EBIT of approximately 110 million EUR is expected.

Drägerwerk AG is an international leader in the markets for medical and safety technology. In 2005, this technology group generated sales of €1,630.8 million. Founded in 1889, Dräger, Lübeck, nowadays employs around 9,700 people in more than 190 countries, hereof more than 50 percent outside of Germany. The Dräger Medical subgroup offers products and services plus integrated system solutions along the entire patient process chain in the CareAreas™ emergency care, perioperative care, critical and perinatal care, as well as home care. The Dräger Safety subgroup's portfolio covers products and system solutions for holistic hazard management: gas detection, personal and property protection products including a wide variety of services. For further information, visit www.draeger.com.

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...